The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis

Detalhes bibliográficos
Autor(a) principal: Aziret, Mehmet
Data de Publicação: 2014
Outros Autores: Irkorucu, Oktay, Reyhan, Enver, Erdem, Hasan, Das, Koray, Ozkara, Selvinaz, Surmelioglu, Ali, Sozen, Selim, Bali, Ilhan, Cetinkunar, Sulleyman, Deger, Kamuran Cumhur
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/96917
Resumo: OBJECTIVES: Vardenafil enhances dilatation of vascular smooth muscle and inhibits platelet aggregation. The purpose of this study was to evaluate the clinical effects of vardenafil and pentoxifylline administration in an experimental model of ischemic colitis. METHODS: Forty female Wistar albino rats weighing 250-300 g were randomized into five experimental groups (each with n = 8) as follows:1) a sham group subjected to a sham surgical procedure and administered only tap water; 2) a control group subjected to a standardized surgical procedure to induce ischemic colitis and administered only tap water; 3) and 4) treatment groups subjected to surgical induction of ischemic colitis followed by the postoperative administration of 5 mg/kg or 10 mg/kg vardenafil, respectively; and 5) a treatment group subjected to surgical induction of ischemic colitis followed by postoperative administration of pentoxifylline at 50 mg/kg/day per day as a single dose for a 3-day period. All animals were sacrificed at 72 h post-surgery and subjected to relaparotomy. We scored the macroscopically visible damage, measured the ischemic area and scored histopathology to determine the severity of ischemia. Tissue malondialdehyde levels were also quantified. RESULTS: The mean Gomella ischemic areas were 63.3 mm2 in the control group; 3.4 and 9.6 mm2 in the vardenafil 5 and vardenafil 10 groups, respectively; and 3.4 mm2 in the pentoxifylline group (p = 0.0001). The mean malondialdehyde values were 63.7 nmol/g in the control group; 25.3 and 25.6 nmol/g in the vardenafil 5 and vardenafil 10 groups, respectively; and 22.8 nmol/g in the pentoxifylline group (p = 0.0001). CONCLUSION: Our findings indicate that vardenafil and pentoxifylline are effective treatment options in an animal model of ischemic colitis. The positive clinical effects produced by these drugs are likely due to their influence on the hemodynamics associated with vascular smooth muscle and platelet functions.
id USP-19_0cb25f0a7974b2f392af619c4f6526b0
oai_identifier_str oai:revistas.usp.br:article/96917
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis OBJECTIVES: Vardenafil enhances dilatation of vascular smooth muscle and inhibits platelet aggregation. The purpose of this study was to evaluate the clinical effects of vardenafil and pentoxifylline administration in an experimental model of ischemic colitis. METHODS: Forty female Wistar albino rats weighing 250-300 g were randomized into five experimental groups (each with n = 8) as follows:1) a sham group subjected to a sham surgical procedure and administered only tap water; 2) a control group subjected to a standardized surgical procedure to induce ischemic colitis and administered only tap water; 3) and 4) treatment groups subjected to surgical induction of ischemic colitis followed by the postoperative administration of 5 mg/kg or 10 mg/kg vardenafil, respectively; and 5) a treatment group subjected to surgical induction of ischemic colitis followed by postoperative administration of pentoxifylline at 50 mg/kg/day per day as a single dose for a 3-day period. All animals were sacrificed at 72 h post-surgery and subjected to relaparotomy. We scored the macroscopically visible damage, measured the ischemic area and scored histopathology to determine the severity of ischemia. Tissue malondialdehyde levels were also quantified. RESULTS: The mean Gomella ischemic areas were 63.3 mm2 in the control group; 3.4 and 9.6 mm2 in the vardenafil 5 and vardenafil 10 groups, respectively; and 3.4 mm2 in the pentoxifylline group (p = 0.0001). The mean malondialdehyde values were 63.7 nmol/g in the control group; 25.3 and 25.6 nmol/g in the vardenafil 5 and vardenafil 10 groups, respectively; and 22.8 nmol/g in the pentoxifylline group (p = 0.0001). CONCLUSION: Our findings indicate that vardenafil and pentoxifylline are effective treatment options in an animal model of ischemic colitis. The positive clinical effects produced by these drugs are likely due to their influence on the hemodynamics associated with vascular smooth muscle and platelet functions. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2014-11-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/9691710.6061/clinics/2014(11)10Clinics; Vol. 69 No. 11 (2014); 763-769Clinics; v. 69 n. 11 (2014); 763-769Clinics; Vol. 69 Núm. 11 (2014); 763-7691980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/96917/95997Copyright (c) 2015 Clinicsinfo:eu-repo/semantics/openAccessAziret, Mehmet Irkorucu, Oktay Reyhan, Enver Erdem, Hasan Das, Koray Ozkara, Selvinaz Surmelioglu, Ali Sozen, Selim Bali, Ilhan Cetinkunar, Sulleyman Deger, Kamuran Cumhur 2015-03-27T18:21:03Zoai:revistas.usp.br:article/96917Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2015-03-27T18:21:03Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis
title The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis
spellingShingle The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis
Aziret, Mehmet
title_short The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis
title_full The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis
title_fullStr The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis
title_full_unstemmed The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis
title_sort The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis
author Aziret, Mehmet
author_facet Aziret, Mehmet
Irkorucu, Oktay
Reyhan, Enver
Erdem, Hasan
Das, Koray
Ozkara, Selvinaz
Surmelioglu, Ali
Sozen, Selim
Bali, Ilhan
Cetinkunar, Sulleyman
Deger, Kamuran Cumhur
author_role author
author2 Irkorucu, Oktay
Reyhan, Enver
Erdem, Hasan
Das, Koray
Ozkara, Selvinaz
Surmelioglu, Ali
Sozen, Selim
Bali, Ilhan
Cetinkunar, Sulleyman
Deger, Kamuran Cumhur
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Aziret, Mehmet
Irkorucu, Oktay
Reyhan, Enver
Erdem, Hasan
Das, Koray
Ozkara, Selvinaz
Surmelioglu, Ali
Sozen, Selim
Bali, Ilhan
Cetinkunar, Sulleyman
Deger, Kamuran Cumhur
description OBJECTIVES: Vardenafil enhances dilatation of vascular smooth muscle and inhibits platelet aggregation. The purpose of this study was to evaluate the clinical effects of vardenafil and pentoxifylline administration in an experimental model of ischemic colitis. METHODS: Forty female Wistar albino rats weighing 250-300 g were randomized into five experimental groups (each with n = 8) as follows:1) a sham group subjected to a sham surgical procedure and administered only tap water; 2) a control group subjected to a standardized surgical procedure to induce ischemic colitis and administered only tap water; 3) and 4) treatment groups subjected to surgical induction of ischemic colitis followed by the postoperative administration of 5 mg/kg or 10 mg/kg vardenafil, respectively; and 5) a treatment group subjected to surgical induction of ischemic colitis followed by postoperative administration of pentoxifylline at 50 mg/kg/day per day as a single dose for a 3-day period. All animals were sacrificed at 72 h post-surgery and subjected to relaparotomy. We scored the macroscopically visible damage, measured the ischemic area and scored histopathology to determine the severity of ischemia. Tissue malondialdehyde levels were also quantified. RESULTS: The mean Gomella ischemic areas were 63.3 mm2 in the control group; 3.4 and 9.6 mm2 in the vardenafil 5 and vardenafil 10 groups, respectively; and 3.4 mm2 in the pentoxifylline group (p = 0.0001). The mean malondialdehyde values were 63.7 nmol/g in the control group; 25.3 and 25.6 nmol/g in the vardenafil 5 and vardenafil 10 groups, respectively; and 22.8 nmol/g in the pentoxifylline group (p = 0.0001). CONCLUSION: Our findings indicate that vardenafil and pentoxifylline are effective treatment options in an animal model of ischemic colitis. The positive clinical effects produced by these drugs are likely due to their influence on the hemodynamics associated with vascular smooth muscle and platelet functions.
publishDate 2014
dc.date.none.fl_str_mv 2014-11-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/96917
10.6061/clinics/2014(11)10
url https://www.revistas.usp.br/clinics/article/view/96917
identifier_str_mv 10.6061/clinics/2014(11)10
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/96917/95997
dc.rights.driver.fl_str_mv Copyright (c) 2015 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2015 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 69 No. 11 (2014); 763-769
Clinics; v. 69 n. 11 (2014); 763-769
Clinics; Vol. 69 Núm. 11 (2014); 763-769
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222761653633024